BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹5.58 Cr | ₹17 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr |
What is the latest Contingent Liabilities ratio of BAL PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹5.58 Cr |
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹16 Cr |
How is Contingent Liabilities of BAL PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.58 Cr | -67.38 | |
| Mar2025 | ₹17 Cr | 0.83 | |
| Mar2024 | ₹17 Cr | 3.16 | |
| Mar2023 | ₹16 Cr | 1.18 | |
| Mar2022 | ₹16 Cr | - | |
Compare Contingent Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹135.7 Cr | 1% | -3.1% | -2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 1% |
-3.1% |
-2% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses